1. Home
  2. LNKS vs ACXP Comparison

LNKS vs ACXP Comparison

Compare LNKS & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKS
  • ACXP
  • Stock Information
  • Founded
  • LNKS 1995
  • ACXP 2017
  • Country
  • LNKS Malaysia
  • ACXP United States
  • Employees
  • LNKS N/A
  • ACXP N/A
  • Industry
  • LNKS
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNKS
  • ACXP Health Care
  • Exchange
  • LNKS NYSE
  • ACXP Nasdaq
  • Market Cap
  • LNKS 8.7M
  • ACXP 8.4M
  • IPO Year
  • LNKS 2024
  • ACXP 2021
  • Fundamental
  • Price
  • LNKS $0.60
  • ACXP $0.35
  • Analyst Decision
  • LNKS
  • ACXP Strong Buy
  • Analyst Count
  • LNKS 0
  • ACXP 2
  • Target Price
  • LNKS N/A
  • ACXP $10.00
  • AVG Volume (30 Days)
  • LNKS 239.8K
  • ACXP 235.0K
  • Earning Date
  • LNKS 06-17-2025
  • ACXP 05-13-2025
  • Dividend Yield
  • LNKS N/A
  • ACXP N/A
  • EPS Growth
  • LNKS N/A
  • ACXP N/A
  • EPS
  • LNKS N/A
  • ACXP N/A
  • Revenue
  • LNKS $5,088,489.00
  • ACXP N/A
  • Revenue This Year
  • LNKS N/A
  • ACXP N/A
  • Revenue Next Year
  • LNKS N/A
  • ACXP N/A
  • P/E Ratio
  • LNKS N/A
  • ACXP N/A
  • Revenue Growth
  • LNKS N/A
  • ACXP N/A
  • 52 Week Low
  • LNKS $0.45
  • ACXP $0.30
  • 52 Week High
  • LNKS $10.27
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • LNKS N/A
  • ACXP 37.87
  • Support Level
  • LNKS N/A
  • ACXP $0.34
  • Resistance Level
  • LNKS N/A
  • ACXP $0.36
  • Average True Range (ATR)
  • LNKS 0.00
  • ACXP 0.02
  • MACD
  • LNKS 0.00
  • ACXP -0.00
  • Stochastic Oscillator
  • LNKS 0.00
  • ACXP 5.19

About LNKS LINKERS INDUSTRIES LIMITED

Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: